Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities
C. Arenas Linares, Anjana Varghese, Aruni Ghose, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13215-13215
Open Access | Times Cited: 13

Showing 13 citing articles:

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 70
An Overview of Immune Checkpoint Inhibitor Toxicities in Bladder Cancer
Avenie Mavadia, Sunyoung Choi, Ayden Ismail, et al.
Toxicology Reports (2024), pp. 101732-101732
Open Access | Times Cited: 6
LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas
Ruiting Huang, Ying Kong, Zhiqing Luo, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 483-483
Open Access | Times Cited: 5
Advances in CAR-T therapy for central nervous system tumors
Delian Zhou, Xiaojian Zhu, Yi Xiao
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Advancing Glioblastoma Therapy: Learning From the Past and Innovations for the Future
Mandeep Rana, Ke-Chi Liou, Amandeep Thakur, et al.
Cancer Letters (2025), pp. 217601-217601
Closed Access
Advancing brain tumor diagnosis: Deep siamese convolutional neural network as a superior model for MRI classification
Gowtham Murugesan, Pavithra Nagendran, Jeyakumar Natarajan
Brain‐X (2025) Vol. 3, Iss. 2
Open Access
Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment
Tongzheng Chen, Wenbin Ma, Xin Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Innovative drug delivery strategies for targeting glioblastoma: overcoming the challenges of the tumor microenvironment
Shubham Khot, A. Krishnaveni, Sankalp Gharat, et al.
Expert Opinion on Drug Delivery (2024)
Closed Access | Times Cited: 2
METTL3/MALAT1/ELAVL1 Axis Promotes Tumor Growth in Ovarian Cancer
Jian Xiong, Wenqin Lian, Rui Zhao, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 85-97
Open Access | Times Cited: 1
Bevacizumab-induced immune thrombocytopenia in an ovarian cancer patient with mixed connective tissue disease: case report and literature review
Yunting Zhang, Fanchun Yang, Jining Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Antitumoral Activity of Electrospray-Nanoencapsulated Tannic Acid on C6 and U87MG Glioblastoma Cell Lines
William Sanabria Simões, Raphaela Cassol Piccoli, Francieli da Silva dos Santos, et al.
BioNanoScience (2024) Vol. 14, Iss. 3, pp. 2886-2898
Closed Access | Times Cited: 1
S100A11 is a potential prognostic biomarker and correlated with tumor immunosuppressive microenvironment in glioma
Jikang Fan, Xuya Wang, Xuejun Yang
Medicine (2024) Vol. 103, Iss. 51, pp. e40701-e40701
Open Access | Times Cited: 1
AI-Guided Cancer Therapy for Patients with Coexisting Migraines
David B. Olawade, Jennifer Teke, Khadijat Adeleye, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3690-3690
Open Access
Page 1

Scroll to top